MICRONASE Drug Patent Profile

✉ Email this page to a colleague

When do Micronase patents expire, and when can generic versions of Micronase launch?

Micronase is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MICRONASE is glyburide. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the glyburide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Micronase

A generic version of MICRONASE was approved as glyburide by TEVA on August 29^th, 1995.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MICRONASE?
What are the global sales for MICRONASE?
What is Average Wholesale Price for MICRONASE?

Summary for MICRONASE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	152
Clinical Trials:	6
Patent Applications:	4,324
Formulation / Manufacturing:	see details
DailyMed Link:	MICRONASE at DailyMed

Drug patent expirations by year for MICRONASE

Recent Clinical Trials for MICRONASE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Texas Tech University Health Sciences Center, El Paso	Early Phase 1
Washington University School of Medicine	Phase 1
United States Department of Defense	Phase 1

See all MICRONASE clinical trials

US Patents and Regulatory Information for MICRONASE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-001	May 1, 1984		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-002	May 1, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-003	May 1, 1984		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MICRONASE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-002	May 1, 1984	⤷ Sign Up	⤷ Sign Up
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-003	May 1, 1984	⤷ Sign Up	⤷ Sign Up
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-001	May 1, 1984	⤷ Sign Up	⤷ Sign Up
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-001	May 1, 1984	⤷ Sign Up	⤷ Sign Up
Pfizer	MICRONASE	glyburide	TABLET;ORAL	017498-003	May 1, 1984	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MICRONASE

See the table below for patents covering MICRONASE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Iceland	756		⤷ Sign Up
United Kingdom	1171935		⤷ Sign Up
Netherlands	6610580		⤷ Sign Up
Switzerland	529115	Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen (Benzenesulphonylureas hypoglycaemics)	⤷ Sign Up
India	139501	PROCESS FOR THE MANUFACTURE OF BENZENSULFONYL-UREAS	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for MICRONASE

Recent Clinical Trials for MICRONASE

Make Better Decisions: Try a trial or see plans & pricing